A CLINICAL STUDY TO EVALUATE THE EFFECTS OF DARUSENTAN ON SAFETY AND EFFICACY IN SUBJECTS WITH RESISTANT SYSTOLIC HYPERTENSION RECEIVING COMBINATION THERAPY WITH THREE OR MORE BLOOD PRESSURE LOWERING DRUGS: